Gunnar Gårdemyr
Chaiman of the Board since 2021. Born 1959.
Education: BA Economics, Lund University
Other assignments: Chairman of the Board RhoVac AB, Board Member Xspray AB.
Previous assignments in the past five years: Board Member Asgard Therapeutics AB.
Holding: 11,000 shares
Independent in relation to the Company’s major shareholders and the Company and management.
Mats Johansson
Chairman of the Board 2013-2020. Board member 2021. Born 1961.
Education: High School
Other assignments: Board Chairman, SiB Solutions AB and EasyDepot AB. Board member, KlaraBo Sverige AB, Abrax Holding AB, Zenit Design Group AB, Nudging Capital AB and Easy Depot AB.
Previous assignments in the past five years: Board member Flygstaben Fastighets AB, ZetaDisplay Sverige AB, ZetaDisplay Danmark A/S, ZetaDisplay Finland OY, Seasam OY and ProntoTV AS. Deputy Board member, Quest Technology Ventures AB. Board member, KlaraBo Bygg AB, KlaraBo Bjuv AB, KlaraBo Svalöv AB, Fastighetsbolaget KlaraBo AB, ZetaDisplay AB, KlaraBo Förvaltning AB.
Holding: 970,500 shares
Dependent in relation to the Company’s major shareholders and the Company and management.
Orest Lastow
Board member since 2013. Born 1964.
Education: MSc, Engineering Physics, Lund University. PhD, Aerosol Physics, Brunel University, London.
Other assignments: Board member, Lastow Consulting AB and Torna Hällestad Fastighets AB.
Previous assignments in the past five years: Board member, XO Sweden Wines & Spirits AB.
Holding: 826,400 shares
Dependent in relation to the Company’s major shareholders and the Company and management.
Berndt Axelsson
Board member since 2013. Born 1959.
Education: BA, Economics, Växjö University
Other assignments: CEO and Board member, Flokk AB and Fastighets AB Stolhuset. Board member, Malmstolen AB, Malmstolen Produktion AB, Malmstolen AS, OFFECCT AB, and BAN Business Consulting AB. Board Chairman, Nässjö Näringsliv AB and INVID Jönköping AB.
Previous assignments in the past five years: Board Chairman, Zenit Design Group AB, Ergonomiprodukter i Bodafors AB.
Holding: 315,600 shares
Independent in relation to the Company’s major shareholders and the Company and management.
Sven Totté
Board member since 2017. Born 1969.
Education: Master in Engineering, Electromechanics & Automation and Degree in Business Economics & Master in Business Administration from University of Antwerp, Belgium and Corporate Governance training from EFL, Lund University.
Other assignments: CEO, Owner and Management Consultant, Totté & Co AB. Board chairman at Gäddan AB. Board member at Norban AB.
Previous assignments in the past five years: CEO and Board member, Systemtext AB. CEO, Axiell Finland OY & Axiell UK Ltd. Executive Vice President Sales at Axiell Group AB. Board member, Century Analytics AB.
Holding: 24,000 shares
Independent in relation to the Company’s major shareholders and the Company and management.
Maria Bech
Board member since 2018. Born 1968.
Education: MSc, Molecular Biology, Lund University
Other assignments: Board member, Neuronano AB, EQL Pharma AB and Paxman AB. CEO, EpiEndo Pharmaceuticals. Founder and Board member, Bech Pharma Consulting AB.
Previous assignments in the past five years: VP Clinical Development & Regulatory Affairs at Karo Bio AB. Chief Scientific Officer at Smartfish AS. Owner of sole proprietorship Carassius Consulting.
Holding: 2,000 shares
Independent in relation to the Company’s major shareholders and the Company and management.
Leif Bergvall Hansen
Board member since 2018. Born 1966.
Education: MSc, Copenhagen Business School
Other assignments: Board member Farmfood AS. CEO, Bergvall Hansen Holding Aps.
Previous assignments in the past five years: CEO, Scandi Standard AB.
Holding: 25,974 shares
Independent in relation to the Company’s major shareholders and the Company and management.
Agneta Walhagen
Board member since 2019. Born 1960.
Education: PhD, Analytical Science
Other assignments: Management Position: Senior Director R&D Science Information and Alliance Management at LEO Pharma.
Previous assignments in the past five years: -
Holding: 3,470 shares
Independent in relation to the Company’s major shareholders and the Company and management.
Ann Gidner
Board member since 2021. Born 1966.
Education:
MSc Chemical Engineering Bioprocessing, Lund University and École Nationale Supérieure d’Ingénieurs de Génie Chimique de Toulouse, MBA, Lund University. Diplôme de Francais, Étoile, Paris.
Other assignments: CEO, SelectImmune Pharma AB. CEO & Owner, Agiris.
Previous assignments in the past five years: CEO, AcuCort AB. Board member, SenzaGen AB. Business Unit Head Clinical Trial Services, Inceptua GmbH, Berlin. Licensing Director, Novozymes Biopharma A/S, Köpenhamn.
Holding: -
Independent in relation to the Company’s major shareholders and the Company and management.